Desktop Site
|
24 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,852.94
+114.49
+0.16 %
Corporate Announcement
Security Code
500087
Company
CIPLA LTD.
Exchange Received Time
14/11/2019 16:01:08
Exchange Disseminated Time
14/11/2019 16:01:17
Time Taken
00:00:09
USFDA Routine Cgmp Inspection Completed At Cipla''s Manufacturing Facility In Patalganga |
11/14/2019 4:01:10 PM
We would like to inform you that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection for both Formulations and APis at our manufacturing facility in Patalganga from 4th November, 2019 to 13th November, 2019.
The inspection ended with 4 observations, none of which were repeat or related to data integrity. The Company is committed to addressing these observations and will submit its response to the agency within the stipulated time
Attachment
<< Back
Recently Viewed